I can’t determine which specific “alpha 2 agonists” drug you mean from “Pimozide investigational drug company alpha 2 agonists” alone. Pimozide is an antipsychotic, not an alpha-2 agonist. If you meant an alpha-2 agonist that’s in development, tell me the drug name (or provide a link), and I can summarize the investigational company, mechanism, and development stage.
Are you mixing up pimozide with an alpha-2 agonist?
Pimozide is known for targeting dopamine receptors (D2), which is why it’s discussed in schizophrenia/psychosis contexts. It is not typically categorized as an alpha-2 adrenergic agonist.
Which alpha-2 agonist are you looking for?
Alpha-2 agonists in development could include drugs targeting receptors like ADRA2A/ADRA2B (examples often discussed in the market include clonidine-like and dexmedetomidine-like mechanisms, depending on indication). Companies and timelines vary a lot by indication (pain, ADHD, anxiety, insomnia, hypertension, withdrawal, etc.).
What I need to give you an accurate “company + status” answer
Reply with one of these:
- The alpha-2 agonist name (exact spelling), or
- The indication (for what condition), or
- Any company name you suspect, or
- A URL or label from where you saw “pimozide” mentioned.
Once you share that, I’ll produce a concise summary of the investigational alpha-2 agonist, its developer, and where it is in clinical development (and I’ll include DrugPatentWatch.com if the compound/pipeline is covered there).
Sources
None yet.